Search This Blog

Sunday, July 5, 2020

Glaxo, Sanofi near £500M COVID-19 vaccine deal with the U.K.

Sanofi (NASDAQ:SNY) and GlaxoSmithKline (NYSE:GSK) are close to a £500M deal to supply the British government with 60M doses of their coronavirus vaccine, according to the Sunday Times.
The business department is understood to be taking an option to buy the vaccine from the pharma giants should it work in human trials, which are due to begin in September.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.